Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man

J. V. Anderson, A. D. Struthers, N. N. Payne, J. D. H. Slater, S. R. Bloom

    Research output: Contribution to journalArticle

    78 Citations (Scopus)

    Abstract

    We have investigated the interaction between the recently discovered natriuretic factor alpha human atrial natriuretic peptide (alpha h-ANP) and the renin-angiotensin-aldosterone system in man. Angiotensin II infused with placebo produced a significant rise of plasma aldosterone concentration (mean +/- SEM increment 352 +/- 23 pmol/l, n = 7, P less than 0.001). The infusion of alpha h-ANP together with angiotensin II largely abolished the aldosterone response (P less than 0.001). Diastolic blood pressure rose in response to the infusion of angiotensin II with placebo (mean increment 21.0 +/- 0.9 mmHg, P less than 0.001). Systolic blood pressure increased to a lesser degree (mean increment 12.5 +/- 0.7 mmHg, P less than 0.001). The infusion of alpha h-ANP together with angiotensin II significantly blunted the diastolic pressor response (P less than 0.01). This ability of alpha h-ANP to blunt the pressor effect of angiotensin II may be important in the control of systemic blood pressure. The inhibition of angiotensin II-stimulated aldosterone release demonstrates that alpha h-ANP may not only be a circulating natriuretic factor in its own right but that it may also act as a modulator of a related endocrine system.
    Original languageEnglish
    Pages (from-to)507-512
    Number of pages6
    JournalClinical Science
    Volume70
    Issue number5
    DOIs
    Publication statusPublished - May 1986

    Fingerprint

    Atrial Natriuretic Factor
    Aldosterone
    Angiotensin II
    Blood Pressure
    Natriuretic Agents
    Placebos
    Endocrine System
    Renin-Angiotensin System
    human NPPA protein

    Keywords

    • Aldosterone
    • Angiotensin II
    • Atrial natriuretic peptide
    • Natriuresis
    • Natriuretic factor
    • Renin-angiotensin system

    Cite this

    Anderson, J. V. ; Struthers, A. D. ; Payne, N. N. ; Slater, J. D. H. ; Bloom, S. R. / Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man. In: Clinical Science. 1986 ; Vol. 70, No. 5. pp. 507-512.
    @article{6352bb2d5d9b44e88bf3543b09670333,
    title = "Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man",
    abstract = "We have investigated the interaction between the recently discovered natriuretic factor alpha human atrial natriuretic peptide (alpha h-ANP) and the renin-angiotensin-aldosterone system in man. Angiotensin II infused with placebo produced a significant rise of plasma aldosterone concentration (mean +/- SEM increment 352 +/- 23 pmol/l, n = 7, P less than 0.001). The infusion of alpha h-ANP together with angiotensin II largely abolished the aldosterone response (P less than 0.001). Diastolic blood pressure rose in response to the infusion of angiotensin II with placebo (mean increment 21.0 +/- 0.9 mmHg, P less than 0.001). Systolic blood pressure increased to a lesser degree (mean increment 12.5 +/- 0.7 mmHg, P less than 0.001). The infusion of alpha h-ANP together with angiotensin II significantly blunted the diastolic pressor response (P less than 0.01). This ability of alpha h-ANP to blunt the pressor effect of angiotensin II may be important in the control of systemic blood pressure. The inhibition of angiotensin II-stimulated aldosterone release demonstrates that alpha h-ANP may not only be a circulating natriuretic factor in its own right but that it may also act as a modulator of a related endocrine system.",
    keywords = "Aldosterone, Angiotensin II, Atrial natriuretic peptide, Natriuresis, Natriuretic factor, Renin-angiotensin system",
    author = "Anderson, {J. V.} and Struthers, {A. D.} and Payne, {N. N.} and Slater, {J. D. H.} and Bloom, {S. R.}",
    year = "1986",
    month = "5",
    doi = "10.1042/cs0700507",
    language = "English",
    volume = "70",
    pages = "507--512",
    journal = "Clinical Science",
    issn = "0143-5221",
    publisher = "Portland Press",
    number = "5",

    }

    Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man. / Anderson, J. V.; Struthers, A. D.; Payne, N. N.; Slater, J. D. H.; Bloom, S. R.

    In: Clinical Science, Vol. 70, No. 5, 05.1986, p. 507-512.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man

    AU - Anderson, J. V.

    AU - Struthers, A. D.

    AU - Payne, N. N.

    AU - Slater, J. D. H.

    AU - Bloom, S. R.

    PY - 1986/5

    Y1 - 1986/5

    N2 - We have investigated the interaction between the recently discovered natriuretic factor alpha human atrial natriuretic peptide (alpha h-ANP) and the renin-angiotensin-aldosterone system in man. Angiotensin II infused with placebo produced a significant rise of plasma aldosterone concentration (mean +/- SEM increment 352 +/- 23 pmol/l, n = 7, P less than 0.001). The infusion of alpha h-ANP together with angiotensin II largely abolished the aldosterone response (P less than 0.001). Diastolic blood pressure rose in response to the infusion of angiotensin II with placebo (mean increment 21.0 +/- 0.9 mmHg, P less than 0.001). Systolic blood pressure increased to a lesser degree (mean increment 12.5 +/- 0.7 mmHg, P less than 0.001). The infusion of alpha h-ANP together with angiotensin II significantly blunted the diastolic pressor response (P less than 0.01). This ability of alpha h-ANP to blunt the pressor effect of angiotensin II may be important in the control of systemic blood pressure. The inhibition of angiotensin II-stimulated aldosterone release demonstrates that alpha h-ANP may not only be a circulating natriuretic factor in its own right but that it may also act as a modulator of a related endocrine system.

    AB - We have investigated the interaction between the recently discovered natriuretic factor alpha human atrial natriuretic peptide (alpha h-ANP) and the renin-angiotensin-aldosterone system in man. Angiotensin II infused with placebo produced a significant rise of plasma aldosterone concentration (mean +/- SEM increment 352 +/- 23 pmol/l, n = 7, P less than 0.001). The infusion of alpha h-ANP together with angiotensin II largely abolished the aldosterone response (P less than 0.001). Diastolic blood pressure rose in response to the infusion of angiotensin II with placebo (mean increment 21.0 +/- 0.9 mmHg, P less than 0.001). Systolic blood pressure increased to a lesser degree (mean increment 12.5 +/- 0.7 mmHg, P less than 0.001). The infusion of alpha h-ANP together with angiotensin II significantly blunted the diastolic pressor response (P less than 0.01). This ability of alpha h-ANP to blunt the pressor effect of angiotensin II may be important in the control of systemic blood pressure. The inhibition of angiotensin II-stimulated aldosterone release demonstrates that alpha h-ANP may not only be a circulating natriuretic factor in its own right but that it may also act as a modulator of a related endocrine system.

    KW - Aldosterone

    KW - Angiotensin II

    KW - Atrial natriuretic peptide

    KW - Natriuresis

    KW - Natriuretic factor

    KW - Renin-angiotensin system

    U2 - 10.1042/cs0700507

    DO - 10.1042/cs0700507

    M3 - Article

    VL - 70

    SP - 507

    EP - 512

    JO - Clinical Science

    JF - Clinical Science

    SN - 0143-5221

    IS - 5

    ER -